Wutah dodolan YoY sajrone rolas wulan kepungkur: Pluri Inc. (PLUR)

Logo grafis Pluri (PLUR)

The creation of a cellular production ecosystem and the integration of a 3D platform into the bio-industry are scaling the business, which is why the rolling 12-month YoY revenue growth chart on GURU.Markets places the metric value at 9.90. Pluri Inc. (PLUR) maintains a scientific priority through leadership in regenerative medicine via cell-growth innovations, while a strong team of Israeli researchers ensures the stability of the company's human capital potential.

Wutah dodolan YoY sajrone rolas wulan kepungkur: pluri-biotech.com (PLUR) kanggo 11.02.2024 - 18.11.2026

Ringkesan rincian data analitis Pluristem Therapeutics (PLUR)

- nilai pasar lan prakiraan target analis:
- indikator kapitalisasi bursa perusahaan:
Analisis kabeh metrik perusahaan:Pluristem Therapeutics (PLUR)
Produk seri Pluri

Pluri Inc. is scaling the commercialization of biomass for synthetic meat and medicine. Revenue dynamics over the last 12 months are calculated as the percentage deviation of current aggregate income from the same period last year. This metric assesses the viability of the business model amid volatile demand for 3D cellular technologies. It is critical for investors to track the expansion rate of the customer base. Relative revenue growth over four quarters compared to the previous year visualizes the pace of this expansion.

Analisis pesaing Pluri Inc.

Ascendis (ASND) - Wutah pendapatan taun lumaku|MDGL - Wutah dodolan YoY sajrone rolas wulan kepungkur|CORT: Wutah dodolan YoY sajrone rolas wulan kepungkur|RYTM: Wutah dodolan YoY (TTM)|AKRO - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Metsera Therapeutics|MoonLake Corp (MLTX) - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur crinetics.com (CRNX)|Wutah pendapatan YoY sajrone 12 wulan kepungkur newamsterdampharma.com NAMS|Wutah dodolan YoY sajrone rolas wulan kepungkur Soleno Therapeutics Inc SLNO|Wutah dodolan YoY (TTM) Amicus Therapeutics Inc FOLD|89bio Corp - Wutah dodolan YoY (TTM)|Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur Agios Pharmaceuticals Inc (AGIO)|Structure Therapeutics (GPCR) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur MiMedx Group, Inc.|Wutah dodolan YoY sajrone rolas wulan kepungkur Rezolute Bio|Lexicon Pharmaceuticals, Inc. (LXRX) - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY (TTM) MBX|Wutah pendapatan YoY sajrone 12 wulan kepungkur Altimmune, Inc. ALT|Wutah dodolan YoY (TTM) AARD (Aardvark Pharma)|Sagimet Biosciences Inc. (SGMT) - Wutah pendapatan taun lumaku|BIOA: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Dinamika pendapatan YoY sajrone rolas wulan kepungkur BMEA (Biomea Fusion)|QNCX (quincetx.com) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Fractyl - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|VTVT (vTv Therapeutics Inc) - Wutah dodolan YoY (TTM)|Agape ATP - Wutah dodolan taun lumaku|Wutah dodolan YoY (TTM) SYBX|Wutah pendapatan taunan sajrone rolas wulan kepungkur Lipocine Inc|Wutah dodolan YoY sajrone rolas wulan kepungkur Matinas BioPharma Holdings MTNB|Wutah pendapatan taunan sajrone rolas wulan kepungkur Spruce Biosciences (SPRB)|GLTO: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan taun lumaku CTCX|LUMO (Lumos Pharma) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan YoY sajrone 12 wulan kepungkur ONVO|RDUS (Radius Pharmaceuticals) - Wutah dodolan YoY (TTM)